-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- CASI Pharmaceuticals, Inc (DE) Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$19.5M, a 249% decline year-over-year.
- CASI Pharmaceuticals, Inc (DE) Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$41M, a 11.9% decline year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2022 was -$41M, a 11.9% decline from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2021 was -$36.7M, a 24.1% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Net Income (Loss) Attributable to Parent for 2020 was -$48.3M, a 4.9% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)